1. Home
  2. DH vs ONCY Comparison

DH vs ONCY Comparison

Compare DH & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

HOLD

Current Price

$1.06

Market Cap

98.9M

Sector

Technology

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$1.12

Market Cap

94.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DH
ONCY
Founded
2011
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.9M
94.0M
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
DH
ONCY
Price
$1.06
$1.12
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$3.08
$7.33
AVG Volume (30 Days)
248.8K
932.2K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
63.28
N/A
EPS
N/A
N/A
Revenue
$241,521,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.30
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.33
52 Week High
$4.70
$1.51

Technical Indicators

Market Signals
Indicator
DH
ONCY
Relative Strength Index (RSI) 44.24 60.49
Support Level $0.97 $1.10
Resistance Level $1.24 $1.34
Average True Range (ATR) 0.09 0.08
MACD 0.02 0.02
Stochastic Oscillator 43.75 95.32

Price Performance

Historical Comparison
DH
ONCY

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: